The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodies

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1153-1167

  Brezski, Randall J ^a   Knight, David M ^a   Jordan, Robert E ^a  

^a CENTOCOR INC   (United States)

Author keywords

Antibody dependent cellular cytotoxicity; Autoantibodies; Complement; Monoclonal antibodies

Indexed keywords

ABCIXIMAB; AMINO ACID; AUTOANTIBODY; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G HINGE AUTOANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; HINGE EXON; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INFECTION RESISTANCE; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN CLEAVAGE; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; STREPTOCOCCUS PYOGENES; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; B-LYMPHOCYTES; HINGE EXONS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MODELS, IMMUNOLOGICAL;

EID: 79958107086     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.107     Document Type: Short Survey

References (80)

1. Baumgarth, N. (2011) The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11, 34-46.
2. Lutz, H.U., Binder, C.J., and Kaveri, S. (2009) Naturally occurring auto-antibodies in homeostasis and disease. Trends Immunol. 30, 43-51.
3. Avrameas, S. (1992) Natural Autoantibodies: Self-Recognition and Physiological Autoimmunity. CRC Press, Boca Raton, FL.
4. Welschof, M., Terness, P., Kipriyanov, S.M., Stanescu, D., Breitling, F., Dorsam, H., Dubel, S., Little, M., and Opelz, G. (1997) The antigen-binding domain of a human IgG-anti-F(ab′)2 autoantibody. Proc. Natl. Acad. Sci. U. S. A. 94, 1902-1907.
5. Terness, P., Navolan, D., Dufter, C., Welschof, M., and Opelz, G. (2002) Immunosuppressive anti-immunoglobulin autoantibodies: specificity, gene structure and function in health and disease. Cell. Mol. Biol. (Noisy-le-grand) 48, 271-278.
6. Brezski, R.J., Luongo, J.L., Petrone, D., Ryan, M.H., Zhong, D., Tam, S.H., Schmidt, A.P., Kruszynski, M., Whitaker, B.P., Knight, D.M., and Jordan, R.E. (2008) Human anti-IgG1 hinge autoantibodies reconstitute the effector functions of proteolytically inactivated IgGs. J. Immunol. 181, 3183-3192.
7. Mandy, W.J. (1967) A new serum factor in normal rabbits. 3. Specificity for antigenic determinants uncovered by papain or pepsin digestion. J. Immunol. 99, 815-824.
8. Mandy, W.J. and Lewis, F.B. (1966) Homoreactant: a new serum factor in "normal" rabbits. Nature 212, 791-792.
9. Terness, P., Kirschfink, M., Navolan, D., Dufter, C., Kohl, I., Opelz, G., and Roelcke, D. (1995) Striking inverse correlation between IgG anti-F(ab′)2 and autoantibody production in patients with cold agglutination. Blood 85, 548-551.
10. Susal, C., Oberg, H.H., Daniel, V., Dorr, C., Terness, P., Huth-Kuhne, A., Zimmermann, R., and Opelz, G. (1994) Isotypes and IgG subclasses of anti-Fab antibodies in human immunodeficiency virus-infected hemophilia patients. Vox Sang. 66, 37-45. (Pubitemid 24017155)
11. Persselin, J.E. and Stevens, R.H. (1985) Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis. J. Clin. Invest. 76, 723-730. (Pubitemid 15023128)
12. Williams, R.C., Jr., Malone, C.C., Huffman, G.R., Silvestris, F., Croker, B.P., Ayoub, E.M., and Massengill, S. (1995) Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab′)2) system. J. Rheumatol. 22, 1075-1085.
13. Fumia, S., Goede, J.S., Fischler, M., Luginbuhl, A., Frick, S., Fodor, P., and Lutz, H.U. (2008) Human F(ab′)(2)-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo. Mol. Immunol. 45, 2951-2961.
14. von Boehmer, H. and Melchers, F. (2010) Checkpoints in lymphocyte development and autoimmune disease. Nat. Immunol. 11, 14-20.
15. Roy, B., Shukla, S., Lyszkiewicz, M., Krey, M., Viegas, N., Duber, S., and Weiss, S. (2009) Somatic hypermutation in peritoneal B1b cells. Mol. Immunol. 46, 1613-1619.
16. Sauerborn, M. and Schellekens, H. (2009) B-1 cells and naturally occurring antibodies: influencing the immunogenicity of recombinant human therapeutic proteins? Curr. Opin. Biotechnol. 20, 715-721.
17. Ehrenstein, M.R. and Notley, C.A. (2010) The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10, 778-786.
18. Wardemann, H., Yurasov, S., Schaefer, A., Young, J.W., Meffre, E., and Nussenzweig, M.C. (2003) Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377. (Pubitemid 37075812)
19. Nemazee, D.A. and Burki, K. (1989) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562-566. (Pubitemid 19045542)
20. Norvell, A., Mandik, L., and Monroe, J.G. (1995) Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J. Immunol. 154, 4404-4413.
21. Radic, M.Z., Erikson, J., Litwin, S., and Weigert, M. (1993) B lymphocytes may escape tolerance by revising their antigen receptors. J. Exp. Med. 177, 1165-1173. (Pubitemid 23097405)
22. Cambier, J.C., Gauld, S.B., Merrell, K.T., and Vilen, B.J. (2007) B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7, 633-643. (Pubitemid 47123549)
23. Halverson, R., Torres, R.M., and Pelanda, R. (2004) Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 5, 645-650. (Pubitemid 38811890)
24. Meffre, E. and Wardemann, H. (2008) B-cell tolerance checkpoints in health and autoimmunity. Curr. Opin. Immunol. 20, 632-638.
25. Ahmed, R. and Gray, D. (1996) Immunological memory and protective immunity: understanding their relation. Science 272, 54-60. (Pubitemid 26110754)
26. McHeyzer-Williams, L.J. and McHeyzer-Williams, M.G. (2005) Antigen-specific memory B cell development. Annu. Rev. Immunol. 23, 487-513. (Pubitemid 40563178)
27. Rajewsky, K. (1996) Clonal selection and learning in the antibody system. Nature 381, 751-758.
28. Tiller, T., Tsuiji, M., Yurasov, S., Velinzon, K., Nussenzweig, M.C., and Wardemann, H. (2007) Autoreactivity in human IgG+ memory B cells. Immunity 26, 205-213. (Pubitemid 46329436)
29. Fagarasan, S., Kinoshita, K., Muramatsu, M., Ikuta, K., and Honjo, T. (2001) In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413, 639-643. (Pubitemid 32964064)
30. William, J., Euler, C., Christensen, S., and Shlomchik, M.J. (2002) Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297, 2066-2070.
31. Tiller, T., Meffre, E., Yurasov, S., Tsuiji, M., Nussenzweig, M.C., and Wardemann, H. (2008) Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329, 112-124. (Pubitemid 350235462)
32. Porter, R.R. (1958) Separation and isolation of fractions of rabbit gamma-globulin containing the antibody and antigenic combining sites. Nature 182, 670-671.
33. Nisonoff, A., Wissler, F.C., and Lipman, L.N. (1960) Properties of the major component of a peptic digest of rabbit antibody. Science 132, 1770-1771.
34. Kormeier, L.C., Ing, J.T., and Mandy, W.J. (1968) Specificity of antiglobulin factors in normal human serum reacting with enzyme digested gamma-G-globulin. J. Immunol. 100, 612-621.
35. Silvestris, F., Williams, R.C., Jr., and Searles, R.P. (1986) Human anti-F(ab′)2 antibodies and pepsin agglutinators react with Fv determinants. Scand. J. Immunol. 23, 499-508. (Pubitemid 16078697)
36. Davey, M.P. and Korngold, L. (1982) Association of anti-F (ab′)2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays. Int. Arch. Allergy Appl. Immunol. 67, 278-283. (Pubitemid 12180125)
37. Osterland, C.K., Harboe, M., and Kunkel, H.G. (1963) Anti-gamma-globulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies. Vox Sang. 8, 133-152.
38. Heimer, R., Wolfe, L.D., and Abruzzo, J.L. (1985) The specificity of antibodies to the F(ab′)2 fragment of human IgG. Arthritis Rheum. 28, 562-568. (Pubitemid 15109909)
39. Natvig, J.B. (1970) Human anti-gamma-globulin antibodies specific for gamma G heavy chain subclasses. Immunology 19, 125-135.
40. Mellbye, O.J. and Natvig, J.B. (1971) Evidence for immune complexes containing antibody to the pepsin site of IgG in rheumatoid synovial fluids. Clin. Exp. Immunol. 8, 889-899.
41. Waller, M. and Curry, N. (1970) The demonstration of plasmin agglutinators in human sera. Vox Sang. 19, 34-46.
42. Waller, M., Curry, N., and Mallory, J. (1968) Immunochemical and serological studies of enzymatically fractionated human IgG globulins. I. Hydrolysis with pepsin, papain, ficin and bromelin. Immunochemistry 5, 577-583.
43. Chuba, J.V. (1994) Susceptibility of monoclonal IgG paraproteins to plasmic cleavage using glycerin-stabilized human plasmin. Biochem. Biophys. Res. Commun. 202, 367-373.
44. Waller, M. and Blaylock, K. (1966) Further studies on the anti-globulin factors in human serum to the pepsin digested fragment of the Ri anti-Rh antibody. J. Immunol. 97, 438-443.
45. Carrico, R.J., Beagle, R., Usategui-Gomez, M., and Deinhardt, F. (1974) A radioimmunoassay specific for the antigenic determinants exposed by pepsin digestion of human immunoglobulin G. Immunochemistry 11, 573-579.
46. Ling, N.R. and Drysdale, P. (1981) Antibodies in human sera to F(ab′)2 fragments of monoclonal and polyclonal IgG. Int. Arch. Allergy Appl. Immunol. 66, 459-463. (Pubitemid 12236812)
47. Persselin, J.E. and Stevens, R.H. (1989) Detection and significance of anti-Fab autoantibody. Monogr. Allergy 26, 74-81.
48. Terness, P., Kohl, I., Hubener, G., Battistutta, R., Moroder, L., Welschof, M., Dufter, C., Finger, M., Hain, C., Jung, M., et al. (1995) The natural human IgG anti-F(ab′)2 antibody recognizes a conformational IgG1 hinge epitope. J. Immunol. 154, 6446-6452.
49. Nasu, H., Chia, D.S., Knutson, D.W., and Barnett, E.V. (1980) Naturally occurring human antibodies to the F(ab′)2portion of IgG. Clin. Exp. Immunol. 42, 378-386. (Pubitemid 10008808)
50. 2 reactivity with variable- and constant-region lambda light-chain epitopes. J. Clin. Immunol. 15, 349-362.
51. Diemel, R.V., ter Hart, H.G.J., Derksen, G.J.A., Koenderman, A.H.L., and Aalberse, R.C. (2005) Characterization of immunoglobulin G fragments in liquid intravenous immunoglobulin products. Transfusion 45, 1601-1609.
52. Gearing, A.J.H., Thorpe, S.J., Miller, K., Mangan, M., Varley, P.G., Dudgeon, T., Ward, G., Turner, C., and Thorpe, R. (2002) Selective cleavage of human IgG by matrix metalloproteinases, matrilysin and stromelysin. Immunol. Lett. 81, 41-48. (Pubitemid 34159039)
53. Ryan, M.H., Petrone, D., Nemeth, J.F., Barnathan, E., Bjorck, L., and Jordan, R.E. (2008) Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol. Immunol. 45, 1837-1846.
54. von Pawel-Rammingen, U., Johansson, B.P., and Bjorck, L. (2002) IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 21, 1607-1615. (Pubitemid 34614617)
55. Coussens, L.M., Fingleton, B., and Matrisian, L.M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392. (Pubitemid 34270240)
56. Egeblad, M. and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174. (Pubitemid 37328786)
57. Brezski, R.J. and Jordan, R.E. (2010) Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? MAbs 2, 212-220.
58. Welschof, M., Reineke, U., Kleist, C., Kipriyanov, S., Little, M., Volkmer-Engert, R., Schneider-Mergener, J., Opelz, G., and Terness, P. (1999) The antigen binding domain of non-idiotypic human anti-F(ab′)2 autoantibodies: study of their interaction with IgG hinge region epitopes. Hum. Immunol. 60, 282-290. (Pubitemid 29239562)
59. 2 antibody recognizes a conformational IgG1 hinge epitope. J. Immunol. 154, 6446-6452.
60. Burton, D.R. (1985) Immunoglobulin G: functional sites. Mol. Immunol. 22, 161-206.
61. Duncan, A.R., Woof, J.M., Partridge, L.J., Burton, D.R., and Winter, G. (1988) Localization of the binding site for the human high-affinity Fc receptor on IgG. Nature 332, 563-564.
62. Frangione, B. and Milstein, C. (1968) Variations in the S-S bridges of immunoglobins G: interchain disulfide bridges of gamma G3 myeloma proteins. J. Mol. Biol. 33, 893-906.
63. Schmidt, A., DeRiggi, D., Jordan, R.E., Whitaker, B., Heavner, G.A., and Kruszynski, M. (2009) A synthetic peptide approach for elucidating the points of natural auto-antibody reactivity to proteolytic fragments of human IgG. Adv. Exp. Med. Biol. 611, 411-412.
64. Baici, A., Knopfel, M., and Fehr, K. (1982) Cleavage of the four human IgG subclasses with cathepsin G. Scand. J. Immunol. 16, 487-498. (Pubitemid 13207211)
65. Vincents, B., von Pawel-Rammingen, U., Björck, L., and Abrahamson, M. (2004) Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 43, 15540-15549. (Pubitemid 39647479)
66. Brezski, R.J., Vafa, O., Petrone, D., Tam, S.H., Powers, G., Ryan, M.H., Luongo, J.L., Oberholtzer, A., Knight, D.M., and Jordan, R.E. (2009) Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge. Proc. Natl. Acad. Sci. U. S. A. 106, 17864-17869.
67. Waller, M., Duma, R.J., Farley, E.D., Jr., and Atkinson, J. (1971) The influence of infection on titres of antiglobulin antibodies. Clin. Exp. Immunol. 8, 451-459.
68. Susal, C., Daniel, V., Oberg, H.H., Terness, P., Huth-Kuhne, A., Zimmerman, R., and Opelz, G. (1992) Striking inverse association of IgG-anti-Fab gamma antibodies and CD4 cell counts in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Blood 79, 954-957.
69. Susal, C., Maier, H., Lorenz, K., and Opelz, G. (1994) Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer. Int. J. Cancer 57, 47-50. (Pubitemid 24117098)
70. Terness, P., Berteli, A., Susal, C., and Opelz, G. (1992) Regulation of antibody response by an IgG-anti-Ig autoantibody occurring during alloimmunization. II. Selective inactivation of antigen receptor-occupied B cells. Transplantation 54, 92-96.
71. Susal, C., Kropelin, M., Groth, J., Wiesel, M., May, G., Carl, S., Staehler, G., and Opelz, G. (1996) Protective effect of autoantibodies against the hinge region of human IgG in kidney graft recipients. Transplantation 62, 1534-1536. (Pubitemid 26404687)
72. Staak, A., Renner, F., Suesal, C., Dietrich, H., Rainer, L., Kamali-Ernst, S., Ernst, W., Padberg, W., Opelz, G., and Weimer, R. (2006) Immunoglobulin induction therapy in renal transplant recipients: effects on immunoglobulin and regulatory antibody levels. Transplant. Proc. 38, 3483-3485. (Pubitemid 44908428)
73. Terness, P., Navolan, D., Moroder, L., Siedler, F., Weyher, E., Kohl, I., Dufter, C., Welschof, M., Drugarin, D., Schneider, F., and Opelz, G. (1996) A natural IgA-anti-F(ab′)2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope. J. Immunol. 157, 4251-4257. (Pubitemid 126449540)
74. Vidarte, L., Pastor, C., Mas, S., Blazquez, A.B., de los Rios, V., Guerrero, R., and Vivanco, F. (2001) Serine 132 is the C3 covalent attachment point on the CH1 domain of human IgG1. J. Biol. Chem. 276, 38217-38223.
75. Knight, D.M., Wagner, C., Jordan, R., McAleer, M.F., DeRita, R., Fass, D.N., Coller, B.S., Weisman, H.F., and Ghrayeb, J. (1995) The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions. Mol. Immunol. 32, 1271-1281. (Pubitemid 26015106)
76. Fick, R.B., Jr., Baltimore, R.S., Squier, S.U., and Reynolds, H.Y. (1985) IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis. J. Infect. Dis. 151, 589-598. (Pubitemid 15102153)
77. Curtis, B.R., Swyers, J., Divgi, A., McFarland, J.G., and Aster, R.H. (2002) Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets. Blood 99, 2054-2059. (Pubitemid 34525488)
78. Jordan, R.E., Nakada, M.T., and Weisman, H.F. (1999) Abciximab: the first platelet glycoprotein IIb/IIIa receptor antagonist. In Biopharmaceuticals, An Industrial Perspective. Walsh, G. and Murphy, B., Eds. Kluwer Academic, Dordrecht, The Netherlands. pp. 35-71.
79. Yano, S., Kaku, S., Suzuki, K., Terazaki, C., Sakayori, T., Kawasaki, T., Kawamura, K., Sugita, Y., Hoshino, K., and Masuho, Y. (1995) Natural antibodies against the immunoglobulin F(ab′)2 fragment cause elimination of antigens recognized by the F(ab′)2 from the circulation. Eur. J. Immunol. 25, 3128-3133.
80. Kaku, S., Yano, S., Kawasaki, T., Sakai, Y., Suzuki, K., Kawamura, K., Masuho, Y., Satoh, N., Takenaka, T., Landolfi, N.F., and Co, M.S. (1996) Comparison of the antiplatelet agent potential of the whole molecule, F(ab)2 and Fab fragments of humanized anti-GPIIb/IIIa monoclonal antibody in monkeys. Gen. Pharmacol. 27, 435-439.